Non-cytotoxic therapeutics : Past and future : Les cancers de l'ovaire (1re partie)FREEDMAN, R. S.Oncologie (Paris). 2005, Vol 7, Num 7, pp 564-568, issn 1292-3818, 5 p.Article

Testability of software componentsFREEDMAN, R. S.IEEE transactions on software engineering. 1991, Vol 17, Num 6, pp 553-564, issn 0098-5589Article

DISEQUILIBRIUM CARBON, OXYGEN, AND NITROGEN CHEMISTRY IN THE ATMOSPHERES OF HD 189733b AND HD 209458bMOSES, Julianne I; VISSCHER, C; FREEDMAN, R. S et al.The Astrophysical journal. 2011, Vol 737, Num 1, issn 0004-637X, 15.1-15.37, 1Article

Clinical and biological effects of intraperitoneal injections of recombinant interferon-γ and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomaFREEDMAN, R. S; KUDELKA, A. P; PATENIA, R et al.Clinical cancer research. 2000, Vol 6, Num 6, pp 2268-2278, issn 1078-0432Article

In vitro growth inhibition of ovarian cancer cells by decorin : Synergism of action between decorin and carboplatinNASH, M. A; LOERCHER, A. E; FREEDMAN, R. S et al.Cancer research (Baltimore). 1999, Vol 59, Num 24, pp 6192-6196, issn 0008-5472Article

Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervixKUDELKA, A. P; WINN, R; FUEGER, R et al.Clinical cancer research. 1996, Vol 2, Num 8, pp 1285-1288, issn 1078-0432Article

Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinumKAVANAGH, J. J; KUDELKA, A. P; EDWARDS, C. L et al.Clinical cancer research. 1996, Vol 2, Num 5, pp 837-842, issn 1078-0432Article

Atmospheric, evolutionary, and spectral models of the brown dwarf Gliese 229 BMARLEY, M. S; SAUMON, D; GUILLOT, T et al.Science (Washington, D.C.). 1996, Vol 272, Num 5270, pp 1919-1921, issn 0036-8075Article

Intraperitoneal indium-111- and yttrium-90-labeled human IgM (AC6C3-2B12) in nude mice bearing peritoneal carcinomatosisQUADRI, S. M; MALIK, A. B; CHU, H. B et al.The Journal of nuclear medicine (1978). 1996, Vol 37, Num 9, pp 1545-1551, issn 0161-5505Article

Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinomaFREEDMAN, R. S; GIBBONS, J. A; GIEDLIN, M et al.Journal of immunotherapy with emphasis on tumor immunology. 1996, Vol 19, Num 6, pp 443-451, issn 1067-5582Conference Paper

Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapyFREEDMAN, R. S; TOMASOVIC, B; TEMPLIN, S et al.Journal of immunological methods. 1994, Vol 167, Num 1-2, pp 145-160, issn 0022-1759Article

Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2 : a pilot trialFREEDMAN, R. S; EDWARDS, C. L; PLATSOUCAS, C. D et al.Journal of immunotherapy. 1994, Vol 16, Num 3, pp 198-210, issn 1053-8550Conference Paper

Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma : cytotoxicity, growth kinetics and phenotypeLOTZOVA, E; SAVARY, C. A; FREEDMAN, R. S et al.Cancer immunology and immunotherapy. 1990, Vol 31, Num 3, pp 169-175, issn 0340-7004, 7 p.Article

Atmosphere, interior, and evolution of the metal-rich transiting planet HD 149026bFORTNEY, J. J; SAUMON, D; MARLEY, M. S et al.The Astrophysical journal. 2006, Vol 642, Num 1, pp 495-504, issn 0004-637X, 10 p., 1Article

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell linesNASH, M. A; LENZI, R; EDWARDS, C. L et al.Clinical and experimental immunology (Print). 1998, Vol 112, Num 2, pp 172-180, issn 0009-9104Article

Galileo probe measurements of thermal and solar radiation fluxes in the Jovian atmosphere : The galileo probe mission to jupiterSROMOVSKY, L. A; COLLARD, A. D; FRY, P. M et al.Journal of geophysical research. 1998, Vol 103, Num E10, pp 22929-22977, issn 0148-0227Article

Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in miceBORCHARDT, P. E; QUADRI, S. M; FREEDMAN, R. S et al.The Journal of nuclear medicine (1978). 1998, Vol 39, Num 3, pp 476-484, issn 0161-5505Article

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervixKUDELKA, A. P; LEVY, T; JAECKLE, K. A et al.Clinical cancer research. 1997, Vol 3, Num 9, pp 1501-1505, issn 1078-0432Article

Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitroFERRANDINA, G; MELICHAR, B; LOERCHER, A et al.Cancer research (Baltimore). 1997, Vol 57, Num 19, pp 4309-4315, issn 0008-5472Article

Solar and thermal radiation in Jupiter's atmosphere : Initial results of the Galileo probe net flux radiometerSROMOVSKY, L. A; BEST, F. A; COLLARD, A. D et al.Science (Washington, D.C.). 1996, Vol 272, Num 5263, pp 851-854, issn 0036-8075Article

Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytesFREEDMAN, R. S; PLATSOUCAS, C. D.Cancer treatment and research. 1996, Vol 81-82, pp 115-146, issn 0927-3042Article

Assessing alternative technologies for the cost-effective computation of derivativesFREEDMAN, R. S; DIGIORGIO, R.Applied artificial intelligence. 1996, Vol 10, Num 6, pp 491-503, issn 0883-9514Conference Paper

Effects of interleukin-1α on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancerVADHAN-RAJ, S; KUDELKA, A. P; GARRISON, L et al.Journal of clinical oncology. 1994, Vol 12, Num 4, pp 707-714, issn 0732-183XArticle

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamideBURKE, T. W; STRINGER, C. A; MORRIS, M et al.Gynecologic oncology (Print). 1991, Vol 40, Num 3, pp 264-267, issn 0090-8258, 4 p.Article

Humoral modulation of lymphokine-activated killer (LAK)-cell induction in humans : IgG-related and non-IgG inhibitors in sera from cancer patientsRILEY, L. B; PELLIS, N. R; SCHANTZ, S. P et al.International journal of cancer. 1990, Vol 46, Num 5, pp 785-791, issn 0020-7136Article